Loading…
This event has ended. Create your own event on Sched.

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Type: Posters, MIGS/Laser Therapy [clear filter]
Thursday, March 1
 

6:59am EST

7:00am EST

Moderated Poster Session (PO001-PO049) Astor Ballroom PO001: Long-Term Iop Control With One, Two, Or Three Trabecular Micro-Bypass Stents For Open Angle Glaucoma: 54 Month Outcomes Astor BallroomOluwatosin Smith MD PO002: Long-Term Outcomes Of A Prospective Study Of Two Trabecular Micro-Bypass Stents Vs. Prostaglandin In Newly Diagnosed Open-Angle Glaucoma: 5-Year Follow-Up Astor BallroomRobert Fechtner MD PO003: Comparison Of One Vs. Two Trabecular Micro-Bypass Stents Astor BallroomSien Chen MD PO004: Outcomes Through 48 Months Following Standalone Implantation Of Migs With 2 Trabecular Bypass Stents In Eyes With Oag Not Controlled On 1 Medication Astor BallroomJason Bacharach MD PO005: Long-Term 48-Month Outcomes Of Refractory Glaucoma Patients Treated With Two Trabecular Micro-Bypass Stents, One Suprachoroidal Stent, And A Topical Prostaglandin. Astor BallroomHady Saheb MD MPH PO006: To Evaluate (1) Impact Of Implanting 2 Trabecular Bypass Microstents On Intra-Ocular Pressure And Medication Burden. (2) Intra-Operative Assessment Of Dye Uptake By The Episcleral Vasculature As A Predictor... Astor BallroomAndrew Chen MD PO007: Treatment With Standalone Implantation Of 2 Trabecular Micro-Bypass Stents Combined With Topical Prostaglandin In OAG On 2 Preoperative Medications: 4-Year Outcomes. Astor BallroomSteven Vold MD PO008: Single-Surgeon Experience With Trabecular Micro-Bypass Stent Implanted In Combination With Cataract Surgery In Eyes With Prior Medical And/Or Surgical Glaucoma Therapy: 5-Year Outcomes Astor BallroomMichael Stiles MD PO009: IOP And Medication Reduction After MIGS With Second-Generation Trabecular Bypass Stents In OAG Subjects On 1 Preoperative Medication: 30-Month Post-Op Outcomes Astor BallroomSavak Teymoorian MD MBA PO010: MIGS With 2 Second-Generation Trabecular Bypass Stents Combined With Topical Prostaglandin In Eyes With OAG On 2 Preoperative Medications: 30-Month Outcomes Astor BallroomAnand Mantravadi MD PO011: Evaluation Of Second-Generation Trabecular Micro-Bypass Stents In Patients With Mild To Severe Glaucoma : A Canadian Study Astor BallroomJulie Lapointe MD PO012: Predictors Of Clinical Outcomes In Combined Phacoemulsification-Istent Astor BallroomShaza Al-Holou MD PO013: Surgical Outcomes Following Combined Phacoemulsification With Istent Implantation And Ab Interno Trabeculectomy Using The Kahook Dual Blade In Patients With Open Angle Glaucoma Astor BallroomCrystal Le MD MPH PO014: Intermediate Term Outcome Of Istent And Istent Inject In Combination With Phacoemulsification Astor BallroomJithin Yohannan MD MPH PO015: Histologic Analysis Of Trabecular Meshwork Obtained From Kahook Dual Blade Goniotomy Astor BallroomSwarup Swaminathan MD PO016: Early Results Of The Kahook Dual Blade, A Novel Device For The Treatment Of Glaucoma Astor BallroomDavinder Grover MD MPH PO017: Outcomes Of Kahook Dual Blade Goniotomy With And Without Phacoemulsification Cataract Extraction Astor BallroomErin Sieck MD PO018: Six-Month Outcomes Of Goniotomy Performed With The Kahook Dual Blade As A Stand-Alone Glaucoma Procedure Astor BallroomSyril Dorairaj MD PO019: Safety And Efficacy Of Kahook Dual Blade With And Without Phacoemulsification Astor BallroomSze Wong MD PO020: Diurnal IOP Fluctuation After Placement Of An Ab Interno Gelatin Stent In Patients With Glaucoma Astor BallroomArsham Sheybani MD PO021: Evaluation Of Efficacy Of Xen Gel Stent - 6 Month Follow-Up Astor BallroomMarc Toeteberg-Harms MD FEBO PO022: Supraciliary Micro-Stent Is Associated With Lack Of Disease Progression And Minimum Usage Of IOP Lowering Medications In Patients With Poag 2-Years Post-Implantation Astor BallroomBrian Flowers MD PO023: Evaluation Of A 24 Hour Circadian Rhythm Model For Iop After Implant With A Supraciliary Micro-Stent Astor BallroomBrian A. Francis MD PO024: Efficacy Of Standalone And Combined Phacoemulsification/ Ab-Interno Canaloplasty (ABIC) In Patients With Primary Open Angle Glaucoma (POAG) Astor BallroomMark Gallardo MD PO025: Efficacy And Safety Of ABIC In Primary Open Angle Glaucoma (POAG) Over An 18-Month Period Astor BallroomMahmoud Khaimi PO026: Short-Term Outcomes Of Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) Astor BallroomAng Li MD PO027: Outflow Facility Effects Of Three Schlemm's Canal MIGS Astor BallroomCarol Toris PhD PO028: Evaluation Of Micro-Invasive Glaucoma Surgery Devices: A Systematic Review And Meta-Analysis Astor BallroomCindy Hutnik MD PhD PO029: Is There A Role For Microinvasive Glaucoma Surgery In Lowering Intraocular Pressure In Presence Of Prior Incisional Glaucoma Surgeries? Astor BallroomShakeel R. Shareef MD PO030: Qualitative Input To Develop A Health-Related Quality-Of-Life Survey For Glaucoma Patients With Micro-Invasive Glaucoma Devices Astor BallroomQi Cui MD PhD PO031: Identifying And Prioritizing Outcomes That Matter To Patients Considering Minimally Invasive Glaucoma Surgical (MIGS) Devices And Other Treatments For Open-Angle Glaucoma Astor BallroomJimmy Le MA PO032: Efficacy Of Goniosurgery For Newborn Versus Infantile Primary Congenital Glaucoma Astor BallroomHelen Yeung MD PO033: Effectiveness Of 360 Degree Trabeculotomy In Childhood Glaucoma Astor BallroomAnna Do MD PO034: Cataract Surgery And Intraocular Pressure (IOP) Astor BallroomSahar Noorani BA PO035: Toric Intraocular Lens Outcomes In Glaucoma Patients With Advanced Visual Field Loss Astor BallroomReay Brown MD PO036: Posterior Capsular Opacification Rates Following Phacoemulsification In Glaucomatous And Non-Glaucomatous Eyes Astor BallroomJeffrey SooHoo MD PO037: Comparison Of Long-Term Clinical Outcomes Between Micropulse Transscleral Cyclophotocoagulation And Endoscopic Cyclophotocoagulation-Plus Astor BallroomBehzad Amoozgar MD PO038: Pupillary Mydriasis And Recovery After Transscleral Micropulse Cyclophotocoagulation Astor BallroomMarisse Masis MD PO039: Histologic Changes Following Continuous And Micropulse Transscleral Cyclophotocoagulation: A Comparative Study Astor BallroomKareem Moussa MD PO040: Diode Laser Cyclophotocoagulation Experience At The Bascom Palmer Eye Institute: A Comparison Of Slow Coagulation And Standard Coagulation Techniques Astor BallroomMohamed Sayed MD PO041: Results Of Transscleral Diode Cpc In Patients With Good Central Vision Astor BallroomJason Smart MD PO042: Endocyclophotocoagulation Outcomes For Different Glaucoma Types And Stages Astor BallroomMichael Lin MD PO043: A Comparison Between Endoscopic Cyclophotocoagulation-Plus (ECP-Plus) And Anterior ECP For Treatment Of Refractory Glaucoma Astor BallroomMax Feinstein BS PO044: Surgical Outcomes Of Phacoemulsification/Goniosynechialysis With And Without Endocyclophotocoagulation In Patients With Chronic Angle Closure Glaucoma Astor BallroomKetaki Panse BS PO045: Factors Associated With 12-Month Intraocular Pressure Reduction Following Selective Laser Trabeculoplasty In The West Indies Glaucoma Laser Study (WIGLS) Astor BallroomTony Realini MD MPH PO046: Predictors Of Long-Term Attrition After Primary Selective Laser Trabeculoplasty Astor BallroomGillian Treadwell MD PO047: MLT (Micropulse Laser Trabeculoplasty) Or Not? Astor BallroomTed Deng BA PO048: Laser Peripheral Iridotomy For Pediatric Intermittent Angle Closure Glaucoma Astor BallroomWilliam Sponsel MD PO049: The Outcomes Of The Contralateral Eyes Of Patients With Acute Primary Angle Closure Attack After Prophylactic Laser Peripheral Iridotomy Astor BallroomCarina Sanvicente MD